Download PDF
Semin Respir Crit Care Med 2005; 26(5): 502-513
DOI: 10.1055/s-2005-922033
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Pulmonary Amyloidosis in Hematological Disorders

Jean-François Cordier1
  • 1Claude Bernard University, Department of Respiratory Medicine-Reference Center for Orphan Pulmonary Diseases, Louis Pradel University Hospital, Lyon (Bron), France
Further Information

Publication History

Publication Date:
02 November 2005 (online)

    Permissions and Reprints

ABSTRACT

Amyloidosis is defined by tissue deposits of amyloid, a proteic substance with a characteristic spatial structure of β-sheet fibrils assembled into bundles. This structure results in specific staining with Congo red dye, with green birefringence under polarized light microscope. AL amyloid forms from amyloidogenic immunoglobulins produced by clonal plasma cells. Pulmonary amyloidosis may be either part of systemic amyloidosis (primary amyloidosis or associated with myeloma) or organ-limited.

Pulmonary interstitial amyloidosis in systemic amyloidosis is rarely symptomatic unless amyloid deposits severely affect gas exchange alveolar structures, thus resulting in serious respiratory impairment. Localized parenchymal involvement may present as nodular amyloidosis or as amyloid deposits in the vicinity of pulmonary lymphomas. Tracheobronchial amyloidosis, which is not associated with evident clonal proliferation, results in airway stenoses necessitating iterative laser treatment.

Treatment of systemic amyloidosis aims at reducing the clonal cell populations producing amyloidogenic immunoglobulins, using high-dose chemotherapy followed by autologous stem cell transplantation in carefully selected patients. Its efficiency in treating diffuse pulmonary amyloidosis has not been established.

KEYWORDS

Amyloidosis - interstitial lung disease - pulmonary nodule - tracheobronchial stenosis

REFERENCES

  • 1 Picken M M. The changing concepts of amyloid.  Arch Pathol Lab Med. 2001;  125 38-43
    PubMedGoogle Scholar
  • 2 Gertz M A, Lacy M Q, Dispenzieri A. Amyloidosis: recognition, confirmation, prognosis, and therapy.  Mayo Clin Proc. 1999;  74 490-494
    CrossrefPubMedGoogle Scholar
  • 3 Steensma D P. “Congo” red: out of Africa?.  Arch Pathol Lab Med. 2001;  125 250-252
    PubMedGoogle Scholar
  • 4 Falk R H, Comenzo R L, Skinner M. The systemic amyloidoses.  N Engl J Med. 1997;  337 898-909
    CrossrefPubMedGoogle Scholar
  • 5 Merlini G, Bellotti V. Molecular mechanisms of amyloidosis.  N Engl J Med. 2003;  349 583-596
    CrossrefPubMedGoogle Scholar
  • 6 Simms R W, Prout M N, Cohen A S. The epidemiology of AL and AA amyloidosis.  Baillieres Clin Rheumatol. 1994;  8 627-634
    PubMedGoogle Scholar
  • 7 Fenoglio C, Pascal R R. Nodular amyloidosis of the lungs: an unusual case associated with chronic lung disease and carcinoma of the bladder.  Arch Pathol. 1970;  90 577-582
    PubMedGoogle Scholar
  • 8 Glenner G G, Terry W D, Isersky C. Amyloidosis: its nature and pathogenesis.  Semin Hematol. 1973;  10 65-86
    PubMedGoogle Scholar
  • 9 Rajkumar S V, Gertz M A, Kyle R A. Primary systemic amyloidosis with delayed progression to multiple myeloma.  Cancer. 1998;  82 1501-1505
    CrossrefPubMedGoogle Scholar
  • 10 Gertz M A, Kyle R A. Amyloidosis with IgM monoclonal gammopathies.  Semin Oncol. 2003;  30 325-328
    CrossrefPubMedGoogle Scholar
  • 11 Wynne J, Braunwald E. The cardiomyopathies and myocarditides. In: Braunwald E Heart Disease. A Textbook of Cardiovascular Medicine. 5th ed. Philadelphia; WB Saunders 1997: 1404-1463
    Google Scholar
  • 12 Gertz M A, Treon S P. Amyloidosis and Waldenström's macroglobulinemia.  Hematology (Am Soc Hematol Educ Program). 2004;  257-282
    CrossrefPubMedGoogle Scholar
  • 13 Smith R R, Hutchins G M, Moore G W, Humphrey R L. Type and distribution of pulmonary parenchymal and vascular amyloid: correlation with cardiac amyloid.  Am J Med. 1979;  66 96-104
    CrossrefPubMedGoogle Scholar
  • 14 Celli B R, Rubinow A, Cohen A S, Brody J S. Patterns of pulmonary involvement in systemic amyloidosis.  Chest. 1978;  74 543-547
    CrossrefPubMedGoogle Scholar
  • 15 Browning M J, Banks R A, Tribe C R et al.. Ten years' experience of an amyloid clinic: a clinicopathological survey.  Q J Med. 1985;  54 213-217
    PubMedGoogle Scholar
  • 16 Baretton G, Linke R P, Löhrs U. Systemische Amyloidosen. Immunhistochemische Typisierung an Autopsien mit Hilfe, zahlreicher spezifischer Antikörper.  Pathologe. 1990;  11 71-79
    PubMedGoogle Scholar
  • 17 Cordier J F, Loire R, Brune J. Amyloidosis of the lower respiratory tract: clinical and pathologic features in a series of 21 patients.  Chest. 1986;  90 827-831
    CrossrefPubMedGoogle Scholar
  • 18 Cornwell G G, Murdoch W L, Kyle R A, Westermark P, Pitkanen P. Frequency and distribution of senile cardiovascular amyloid: a clinicopathologic correlation.  Am J Med. 1983;  75 618-623
    CrossrefPubMedGoogle Scholar
  • 19 Himmelfarb E, Wells S, Rabinowitz J G. The radiologic spectrum of cardiopulmonary amyloidosis.  Chest. 1977;  72 327-332
    CrossrefPubMedGoogle Scholar
  • 20 Hui A N, Koss M N, Hochholzer L, Wehunt W D. Amyloidosis presenting in the lower respiratory tract: clinicopathologic, radiologic, immunohistochemical, and histochemical studies on 48 cases.  Arch Pathol Lab Med. 1986;  110 212-218
    PubMedGoogle Scholar
  • 21 Kunze W P. Senile pulmonary amyloidosis.  Pathol Res Pract. 1979;  164 413-422
    CrossrefPubMedGoogle Scholar
  • 22 Toriumi J. The lung in generalized amyloidosis.  Acta Pathol Jpn. 1972;  22 141-152
    PubMedGoogle Scholar
  • 23 Utz J P, Swensen S J, Gertz M A. Pulmonary amyloidosis: the Mayo Clinic experience from 1980 to 1993.  Ann Intern Med. 1996;  124 407-413
    PubMedGoogle Scholar
  • 24 Berk J L, O'Regan A, Skinner M. Pulmonary and tracheobronchial amyloidosis.  Semin Respir Crit Care Med. 2002;  23 155-165
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Kaiserling E, Kröber S. Lymphatic amyloidosis, a previously unrecognized form of amyloid deposition in generalized amyloidosis.  Histopathology. 1994;  24 215-221
    PubMedGoogle Scholar
  • 26 Monreal F A. Pulmonary amyloidosis: ultrastructural study of early alveolar septal deposits.  Hum Pathol. 1984;  15 388-390
    PubMedGoogle Scholar
  • 27 Pickford H A, Swensen S J, Utz J P. Thoracic cross-sectional imaging of amyloidosis.  AJR Am J Roentgenol. 1997;  168 351-355
    PubMedGoogle Scholar
  • 28 Geusens E A, Verschakelen J A, Bogaert J G. Primary pulmonary amyloidosis as a cause of interlobular septal thickening.  AJR Am J Roentgenol. 1997;  168 1116-1117
    PubMedGoogle Scholar
  • 29 Graham C M, Stern E J, Finkbeiner W E, Webb W R. High-resolution CT appearance of diffuse alveolar septal amyloidosis.  AJR Am J Roentgenol. 1992;  158 265-267
    PubMedGoogle Scholar
  • 30 Kim H Y, Im J G, Song K S et al.. Localized amyloidosis of the respiratory system: CT features.  J Comput Assist Tomogr. 1999;  23 627-631
    CrossrefPubMedGoogle Scholar
  • 31 Ohdama S, Akagawa S, Matsubara O, Yoshizawa Y. Primary diffuse alveolar septal amyloidosis with multiple cysts and calcification.  Eur Respir J. 1996;  9 1569-1571
    CrossrefPubMedGoogle Scholar
  • 32 Shiue S T, McNally D P. Pulmonary hypertension from prominent vascular involvement in diffuse amyloidosis.  Arch Intern Med. 1988;  148 687-689
    CrossrefPubMedGoogle Scholar
  • 33 Sullivan E J, Schwarz M I. Pulmonary hypertension resulting from primary pulmonary amyloidosis.  Semin Respir Crit Care Med. 1994;  15 238-242
    PubMedGoogle Scholar
  • 34 Dingli D, Utz J P, Gertz M A. Pulmonary hypertension in patients with amyloidosis.  Chest. 2001;  120 1735-1738
    CrossrefPubMedGoogle Scholar
  • 35 Johnson W J, Lie J T. Pulmonary hypertension and familial Mediterranean fever: a previously unrecognized association.  Mayo Clin Proc. 1991;  66 919-925
    PubMedGoogle Scholar
  • 36 Road J D, Jacques J, Sparling J R. Diffuse alveolar septal amyloidosis presenting with recurrent hemoptysis and medial dissection of pulmonary arteries.  Am Rev Respir Dis. 1985;  132 1368-1370
    PubMedGoogle Scholar
  • 37 Case Records of the Massachusetts General Hospital . Case 20-1998.  N Engl J Med. 1998;  338 1905-1913
    CrossrefPubMedGoogle Scholar
  • 38 Kamei K, Kusumoto K, Suzuki T. Pulmonary amyloidosis with pulmonary arteriovenous fistula.  Chest. 1989;  96 1435-1436
    PubMedGoogle Scholar
  • 39 Mazoyer G, Cordier J F, Zabern J M et al.. Métastases pulmonaires des cancers médullaires de la thyroïde: etude de 4 cas: originalité de la forme lymphangitique avec stroma amyloïde.  Rev Mal Respir. 1986;  3 139-143
    PubMedGoogle Scholar
  • 40 Wilson S R, Sanders D E, Delarue N C. Intrathoracic manifestations of amyloid disease.  Radiology. 1976;  120 283-289
    CrossrefPubMedGoogle Scholar
  • 41 Desai R A, Mahajan V K, Benjamin S, Van Ordstrand H S, Cordasco E M. Pulmonary amyloidoma and hilar adenopathy: rare manifestations of primary amyloidosis.  Chest. 1979;  76 170-173
    PubMedGoogle Scholar
  • 42 Gross B H, Felson B, Birnberg F A. The respiratory tract in amyloidosis and the plasma cell dyscrasias.  Semin Roentgenol. 1986;  21 113-127
    PubMedGoogle Scholar
  • 43 Dacic S, Colby T V, Yousem S A. Nodular amyloidoma and primary pulmonary lymphoma with amyloid production: a differential diagnostic problem.  Mod Pathol. 2000;  13 934-940
    PubMedGoogle Scholar
  • 44 Liaw Y S, Kuo S H, Yang P C, Chen C L, Luh K T. Nodular amyloidosis of the lung and the breast mimicking breast carcinoma with pulmonary metastasis.  Eur Respir J. 1995;  8 871-873
    PubMedGoogle Scholar
  • 45 Kung J, Zhuang H, Yu J Q, Duarte P S, Alavi A. Intense fluorodeoxyglucose activity in pulmonary amyloid lesions on positron emission tomography.  Clin Nucl Med. 2003;  28 975-976
    PubMedGoogle Scholar
  • 46 Asad S, Aquino S L, Piyavisetpat N, Fischman A J. False-positive FDG positron emission tomography. Uptake in nonmalignant chest abnormalities.  AJR Am J Roentgenol. 2004;  182 983-989
    PubMedGoogle Scholar
  • 47 Ollenberger G P, Knight S, Tauro A J. False-positive FDG positron emission tomography in pulmonary amyloidosis.  Clin Nucl Med. 2004;  29 657-658
    PubMedGoogle Scholar
  • 48 Laden S A, Cohen M L, Harley R A. Nodular pulmonary amyloidosis with extrapulmonary involvement.  Hum Pathol. 1984;  15 594-597
    PubMedGoogle Scholar
  • 49 Kobayashi H, Mastuoka R, Kitamura S, Tsunoda N, Saito K. Sjögren's syndrome with multiple bullae and pulmonary nodular amyloidosis.  Chest. 1988;  94 438-440
    CrossrefPubMedGoogle Scholar
  • 50 Jeong Y J, Lee K S, Chung M P et al.. Amyloidosis and lymphoproliferative disease in Sjögren syndrome: thin-section computed tomography findings and histopathologic comparisons.  J Comput Assist Tomogr. 2004;  28 776-781
    CrossrefPubMedGoogle Scholar
  • 51 Miura K, Shirasawa H. Lambda III subgroup immunoglobulin light chains are precursor proteins of nodular pulmonary amyloidosis.  Am J Clin Pathol. 1993;  100 561-566
    PubMedGoogle Scholar
  • 52 Lim J K, Lacy M Q, Kurtin P J, Kyle R A, Gertz M A. Pulmonary marginal zone lymphoma of MALT type as a cause of localised pulmonary amyloidosis.  J Clin Pathol. 2001;  54 642-646
    PubMedGoogle Scholar
  • 53 Davis C J, Butchart E G, Gibbs A R. Nodular pulmonary amyloidosis occurring in association with pulmonary lymphoma.  Thorax. 1991;  46 217-218
    PubMedGoogle Scholar
  • 54 Okuda M, Okuda Y, Ogura T et al.. Primary lung involvement with amyloid deposition in Waldenström's macroglobulinemia: observations from over 20 years.  Respirology. 2004;  9 414-418
    CrossrefPubMedGoogle Scholar
  • 55 Nakamura N, Yamada G, Itoh T et al.. Pulmonary MALT lymphoma with amyloid production in a patient with primary Sjogren's syndrome.  Intern Med. 2002;  41 309-311
    CrossrefPubMedGoogle Scholar
  • 56 Miyamoto T, Kobayashi T, Makiyama M et al.. Monoclonality of infiltrating plasma cells in primary pulmonary nodular amyloidosis: detection with polymerase chain reaction.  J Clin Pathol. 1999;  52 464-467
    PubMedGoogle Scholar
  • 57 da Costa P, Corrin B. Amyloidosis localized to the lower respiratory tract: probable immunoamyloid nature of the tracheobronchial and nodular pulmonary forms.  Histopathology. 1985;  9 703-710
    PubMedGoogle Scholar
  • 58 Lee S C, Johnson H. Multiple nodular pulmonary amyloidosis: a case report and comparison with diffuse alveolar-septal pulmonary amyloidosis.  Thorax. 1975;  30 178-185
    PubMedGoogle Scholar
  • 59 Rubinow A, Celli B R, Cohen A S, Rigden B G, Brody J S. Localized amyloidosis of the lower respiratory tract.  Am Rev Respir Dis. 1978;  118 603-611
    PubMedGoogle Scholar
  • 60 Simpson II G T, Strong M S, Skinner M, Cohen A S. Localized amyloidosis of the head and neck and upper aerodigestive and lower respiratory tracts.  Ann Otol Rhinol Laryngol. 1984;  93 374-379
    PubMedGoogle Scholar
  • 61 Toyoda M, Ebihara Y, Kato H, Kita S. Tracheobronchial AL amyloidosis: histologic, immunohistochemical, ultrastructural, and immunoelectron microscopic observations.  Hum Pathol. 1993;  24 970-976
    PubMedGoogle Scholar
  • 62 Capizzi S A, Betancourt E, Prakash U BS. Tracheobronchial amyloidosis.  Mayo Clin Proc. 2000;  75 1148-1152
    CrossrefPubMedGoogle Scholar
  • 63 Diaz-Jimenez J P, Rodriguez A, Martinez Ballarin J I, Castro M J, Argemi T M, Manresa F. Diffuse tracheobronchial amyloidosis.  Journal of Bronchology. 1999;  6 13-17
    PubMedGoogle Scholar
  • 64 Piazza C, Cavaliere S, Foccoli P, Toninelli C, Bolzoni A, Peretti G. Endoscopic management of laryngo-tracheobronchial amyloidosis: a series of 32 patients.  Eur Arch Otorhinolaryngol. 2003;  260 349-354
    PubMedGoogle Scholar
  • 65 O'Regan A, Fenlon H M, Beamis J F, Steele M P, Skinner M, Berk J L. Tracheobronchial amyloidosis: the Boston university experience from 1984 to 1999.  Medicine (Baltimore). 2000;  79 69-79
    CrossrefPubMedGoogle Scholar
  • 66 Clark J M, Weissler M C. Localized laryngotracheobronchial amyloidosis: case report and review of the literature.  Ear Nose Throat J. 2001;  80 632-638
    PubMedGoogle Scholar
  • 67 Crestani B, Monnier A, Kambouchner M, Battesti J P, Reynaud P, Valeyre D. Tracheobronchial amyloidosis with hilar lymphadenopathy associated with a serum monoclonal immunoglobulin.  Eur Respir J. 1993;  6 1569-1571
    PubMedGoogle Scholar
  • 68 Marsot-Dupuch K, Tubiana J M, Chabolle F, Eisenfisz M. L'amylose laryngée et trachéo-bronchique, cause rare de dyspnée: a propos de deux cas.  Ann Radiol (Paris). 1987;  30 347-352
    PubMedGoogle Scholar
  • 69 Case Records of the Massachusetts General Hospital . Case 1-1995.  N Engl J Med. 1995;  332 110-115
    CrossrefPubMedGoogle Scholar
  • 70 Rajan K G, Reynolds S P, McConnochie K, White J P. Localised amyloid presenting as bronchial asthma.  Eur J Respir Dis. 1987;  71 213-215
    PubMedGoogle Scholar
  • 71 Millar A B, O'Reilly A P, Clarke S W, Hetzel M R. Amyloidosis of the respiratory tract treated by laser therapy.  Thorax. 1985;  40 544-545
    PubMedGoogle Scholar
  • 72 Tariq S M, Morrison D, McConnochie K. Solitary bronchial amyloid presenting with haemoptysis.  Eur Respir J. 1990;  3 1230-1231
    PubMedGoogle Scholar
  • 73 Barnes E L, Zafar T. Laryngeal amyloidosis: clinicopathologic study of seven cases.  Ann Otol Rhinol Laryngol. 1977;  86 856-863
    PubMedGoogle Scholar
  • 74 Michaels L, Hyams V J. Amyloid in localised deposits and plasmacytomas of the respiratory tract.  J Pathol. 1979;  128 29-38
    PubMedGoogle Scholar
  • 75 Schulz C, Hauck R W, Nathrath W B, Prauer H W, Linke R P, Emslander H P. Combined amyloidosis of the upper and lower respiratory tract.  Respiration. 1995;  62 163-166
    PubMedGoogle Scholar
  • 76 Thompson L D, Derringer G A, Wenig B M. Amyloidosis of the larynx: a clinicopathologic study of 11 cases.  Mod Pathol. 2000;  13 528-535
    CrossrefPubMedGoogle Scholar
  • 77 Attwood H D, Price C G, Riddell R J. Primary diffuse tracheobronchial amyloidosis.  Thorax. 1972;  27 620-624
    PubMedGoogle Scholar
  • 78 Prowse C B. Amyloidosis of the lower respiratory tract.  Thorax. 1958;  13 308-320
    PubMedGoogle Scholar
  • 79 Prowse C B, Elliott I K. Diffuse tracheo-bronchial amyloidosis: a rare variant of a protean disease.  Thorax. 1963;  18 326-333
    PubMedGoogle Scholar
  • 80 Leske V, Lazor R, Coetmeur D, Crestani B, Chatte G, Cordier J F. Tracheobronchopathia osteochondroplastica: a study of 41 patients.  Medicine (Baltimore). 2001;  80 378-390
    CrossrefPubMedGoogle Scholar
  • 81 Alroy G G, Lichtig C, Kaftori J K. Tracheobronchopathia osteoplastica: end stage of primary lung amyloidosis?.  Chest. 1972;  61 465-468
    PubMedGoogle Scholar
  • 82 Jones A W, Chatterji A N. Primary tracheobronchial amyloidosis with tracheobronchopathia osteoplastica.  Br J Dis Chest. 1977;  71 268-272
    PubMedGoogle Scholar
  • 83 Sakula A. Tracheobronchopathia osteoplastica: its relationship to primary tracheobronchial amyloidosis.  Thorax. 1968;  23 105-110
    PubMedGoogle Scholar
  • 84 Bontemps F, Tillie-Leblond I, Coppin M C et al.. Pleural amyloidosis: thoracoscopic aspects.  Eur Respir J. 1995;  8 1025-1027
    PubMedGoogle Scholar
  • 85 Dubrey S, Mendes L, Skinner M, Falk R H. Resolution of heart failure in patients with AL amyloidosis.  Ann Intern Med. 1996;  125 481-484
    PubMedGoogle Scholar
  • 86 Graham D R, Ahmad D. Clinical aspects of pulmonary amyloidosis.  Chest. 1987;  92 576-577
    PubMedGoogle Scholar
  • 87 Kavuru M S, Adamo J P, Ahmad M, Mehta A C, Gephardt G N. Amyloidosis and pleural disease.  Chest. 1990;  98 20-23
    PubMedGoogle Scholar
  • 88 Knapp M J, Roggli V L, Kim J, Moore J O, Shelburne J D. Pleural amyloidosis.  Arch Pathol Lab Med. 1988;  112 57-60
    PubMedGoogle Scholar
  • 89 Romero Candeira S, Martin Serrano C, Hernandez Blasco L. Amyloidosis and pleural disease.  Chest. 1991;  100 292-293
    PubMedGoogle Scholar
  • 90 Berk J L, Keane J, Seldin D C et al.. Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis.  Chest. 2003;  124 969-977
    CrossrefPubMedGoogle Scholar
  • 91 Adams A L, Castro C Y, Singh S P, Moran C A. Pleural amyloidosis mimicking mesothelioma: a clinicopathologic study of two cases.  Ann Diagn Pathol. 2001;  5 229-232
    PubMedGoogle Scholar
  • 92 Case Records of the Massachusetts General Hospital . Case 48-1977.  N Engl J Med. 1977;  297 1221-1228
    PubMedGoogle Scholar
  • 93 Garcia Gallego F, Calleja Canelas J L. Hilar enlargement in amyloidosis.  N Engl J Med. 1974;  291 531
    PubMedGoogle Scholar
  • 94 Gross B H. Radiographic manifestations of lymph node involvement in amyloidosis.  Radiology. 1981;  138 11-14
    CrossrefPubMedGoogle Scholar
  • 95 Khan J A, Shamsi S H, Rana T A, Hussain S F. Pulmonary amyloidosis: a case with hilar and mediastinal involvement and a review of the literature.  Clin Pulm Med. 1995;  2 66-69
    PubMedGoogle Scholar
  • 96 Kidd C R, Fred H L, Natelson E A. Bilateral hilar adenopathy in amyloidosis.  N Engl J Med. 1974;  290 972
    PubMedGoogle Scholar
  • 97 Naschitz J E, Yeshurun D, Pick A I. Intrathoracic amyloid lymphadenopathy.  Respiration. 1986;  49 73-76
    PubMedGoogle Scholar
  • 98 Jenkins M CF, Potter M. Calcified pseudotumoural mediastinal amyloidosis.  Thorax. 1991;  46 686-687
    PubMedGoogle Scholar
  • 99 Hiller N, Fisher D, Shmesh O, Gottschalk-Sabag S, Dollberg M. Primary amyloidosis presenting as an isolated mediastinal mass: diagnosis by fine needle biopsy.  Thorax. 1995;  50 908-909
    CrossrefPubMedGoogle Scholar
  • 100 Melato M, Antonutto G, Falconieri G, Manconi R. Massive amyloidosis of mediastinal lymph nodes in a patient with multiple myeloma.  Thorax. 1983;  38 151-152
    PubMedGoogle Scholar
  • 101 Osnoss K L, Harrell D D. Isolated mediastinal mass in primary amyloidosis.  Chest. 1980;  78 786-788
    PubMedGoogle Scholar
  • 102 Shaw P, Grossman R, Fernandes B J. Nodular mediastinal amyloidosis.  Hum Pathol. 1984;  15 1183-1185
    PubMedGoogle Scholar
  • 103 Conaghan P, Chung D, Vaughan R. Recurrent laryngeal nerve palsy associated with mediastinal amyloidosis.  Thorax. 2000;  55 436-437
    CrossrefPubMedGoogle Scholar
  • 104 Santiago R M, Scharnhorst D, Ratkin G, Crouch E C. Respiratory muscle weakness and ventilatory failure in AL amyloidosis with muscular pseudohypertrophy.  Am J Med. 1987;  83 175-178
    CrossrefPubMedGoogle Scholar
  • 105 Streeten E A, de la Monte S M, Kennedy T P. Amyloid infiltration of the diaphragm as a cause of respiratory failure.  Chest. 1986;  89 760-762
    CrossrefPubMedGoogle Scholar
  • 106 Carbone J E, Barker D, Stauffer J L. Sleep apnea in amyloidosis.  Chest. 1985;  87 401-403
    CrossrefPubMedGoogle Scholar
  • 107 Lewis J E, Olsen K D, Kurtin P J, Kyle R A. Laryngeal amyloidosis: a clinicopathologic and immunohistochemical review.  Otolaryngol Head Neck Surg. 1992;  106 372-377
    CrossrefPubMedGoogle Scholar
  • 108 Hamed G, Heffess C S, Shmookler B M, Wenig B M. Amyloid goiter: a clinicopathologic study of 14 cases and review of the literature.  Am J Clin Pathol. 1995;  104 306-312
    PubMedGoogle Scholar
  • 109 Gertz M A, Kyle R A. Secondary systemic amyloidosis: response and survival in 64 patients.  Medicine (Baltimore). 1991;  70 246-256
    PubMedGoogle Scholar
  • 110 Kuhlback B, Wegelius O. Secondary amyloidosis: a study of clinical and pathological findings.  Acta Med Scand. 1966;  180 737-745
    PubMedGoogle Scholar
  • 111 Wiman L G, Hofer P A. Amyloidosis and lung diseases.  Scand J Respir Dis. 1974;  55 5-18
    PubMedGoogle Scholar
  • 112 Youakim C, Cottin V, Juillard L, Fouque D, MacGregor B, Cordier J F. Amylose rénale AA secondaire à des bronchectasies.  Rev Mal Respir. 2004;  21 821-824
    PubMedGoogle Scholar
  • 113 Paydas S. Report on 59 patients with renal amyloidosis.  Int Urol Nephrol. 1999;  31 619-631
    CrossrefPubMedGoogle Scholar
  • 114 Hazenberg B PC, van Rijswijk M H. Where has secondary amyloid gone?.  Ann Rheum Dis. 2000;  59 577-579
    CrossrefPubMedGoogle Scholar
  • 115 Kline L R, Dise C A, Ferro T J, Hansen-Flaschen J H. Diagnosis of pulmonary amyloidosis by transbronchial biopsy.  Am Rev Respir Dis. 1985;  132 191-194
    PubMedGoogle Scholar
  • 116 Strange C, Heffner J E, Collins B S, Brown F M, Sahn S A. Pulmonary hemorrhage and air embolism complicating transbronchial biopsy in pulmonary amyloidosis.  Chest. 1987;  92 367-369
    PubMedGoogle Scholar
  • 117 Yood R A, Skinner M, Rubinow A, Talarico L, Cohen A S. Bleeding manifestations in 100 patients with amyloidosis.  JAMA. 1983;  249 1322-1324
    CrossrefPubMedGoogle Scholar
  • 118 Hawkins P N, Pepys M B. Role of heart transplantation in systemic amyloidosis.  J Heart Lung Transplant. 1996;  15 321-322
    PubMedGoogle Scholar
  • 119 Sumeray M S, Murday A J. Pulmonary amyloidosis occurring after heart transplantation for amyloid heart disease.  J Heart Lung Transplant. 1995;  14 402-403
    PubMedGoogle Scholar
  • 120 Hachulla E, Maulin L, Deveaux M et al.. Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: from diagnosis to prognosis.  Am J Med. 1996;  101 77-87
    CrossrefPubMedGoogle Scholar
  • 121 Hawkins P N, Lavender P, Pepys M B. Evaluation of systemic amyloidosis by scintigraphy with 123 I-labeled serum amyloid P component.  N Engl J Med. 1990;  323 508-513
    PubMedGoogle Scholar
  • 122 Bierny J P. Multinodular primary amyloidosis of the lung: diagnosis by needle biopsy.  AJR Am J Roentgenol. 1978;  131 1082-1083
    PubMedGoogle Scholar
  • 123 Dahlgren S E, Lewenhaupt A, Ovenfors C O. Fine needle biopsy diagnosis in nodular pulmonary amyloidosis.  Acta Pathol Microbiol Scand. 1970;  78 1-5
    PubMedGoogle Scholar
  • 124 Möllers M J, Van Schaik J PJ, Van der Putte S CJ. Pulmonary amyloidoma: histologic proof yielded by transthoracic coaxial fine needle biopsy.  Chest. 1992;  102 1597-1598
    PubMedGoogle Scholar
  • 125 Slanetz P J, Whitman G J, Shepard J A, Chew F S. Nodular pulmonary amyloidosis.  AJR Am J Roentgenol. 1994;  163 296
    PubMedGoogle Scholar
  • 126 Tomashefski Jr J F, Cramer S F, Abramowsky C, Cohen A M, Horak G. Needle biopsy diagnosis of solitary amyloid nodule of the lung.  Acta Cytol. 1980;  24 224-227
    PubMedGoogle Scholar
  • 127 Buxbaum J, Gallo G. Nonamyloidotic monoclonal immunoglobulin deposition disease: light-chain, heavy-chain, and light-and heavy-chain deposition diseases.  Hematol Oncol Clin North Am. 1999;  13 1235-1248
    CrossrefPubMedGoogle Scholar
  • 128 Buxbaum J, Genega E M, Lazowski P et al.. Infiltrative nonamyloidotic monoclonal immunoglobulin light chain cardiomyopathy: an underappreciated manifestation of plasma cell dyscrasias.  Cardiology. 2000;  93 220-228
    CrossrefPubMedGoogle Scholar
  • 129 Kijner C H, Yousem S A. Systemic light chain deposition disease presenting as multiple pulmonary nodules: a case report and review of the literature.  Am J Surg Pathol. 1988;  12 405-413
    PubMedGoogle Scholar
  • 130 Piard F, Yaziji N, Jarry O et al.. Solitary plasmacytoma of the lung with light chain extracelluler deposits: a case report and review of the literature.  Histopathology. 1998;  32 356-361
    CrossrefPubMedGoogle Scholar
  • 131 Morinaga S, Watanabe H, Gemma A et al.. Plasmacytoma of the lung associated with nodular deposits of immunoglobulin.  Am J Surg Pathol. 1987;  11 989-995
    PubMedGoogle Scholar
  • 132 Khoor A, Myers J L, Tazelaar H D, Kurtin P J. Amyloid-like pulmonary nodules, including localized light-chain deposition: clinicopathologic analysis of three cases.  Am J Clin Pathol. 2004;  121 200-204
    CrossrefPubMedGoogle Scholar
  • 133 Rostagno A, Frizzera G, Ylagan L, Kumar A, Ghiso J, Gallo G. Tumoral non-amyloidotic monoclonal immunoglobulin light-chain deposits (“aggregoma”): presenting feature of B-cell dyscrasia in three cases with immunohistochemical and biochemical analyses.  Br J Haematol. 2002;  119 62-69
    CrossrefPubMedGoogle Scholar
  • 134 Stokes M B, Jagirdar J, Burchstin O, Kornacki S, Kumar A, Gallo G. Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient.  Mod Pathol. 1997;  10 1059-1065
    PubMedGoogle Scholar
  • 135 Dyke P C, Demaray M J, Delavan J W, Rasmussen R A. Pulmonary amyloidoma.  Am J Clin Pathol. 1974;  61 301-305
    PubMedGoogle Scholar
  • 136 Toty L, Personne C, Colchen A, Vourc'h G. Bronchoscopic management of tracheal lesions using the neodymium yttrium aluminum garnet laser.  Thorax. 1981;  36 175-178
    PubMedGoogle Scholar
  • 137 Monroe A T, Walia R, Zlotecki R A, Jantz M A. Tracheobronchial amyloidosis: a case report of successful treatment with external beam radiation therapy.  Chest. 2004;  125 784-789
    CrossrefPubMedGoogle Scholar
  • 138 Kalra S, Utz J P, Edell E S, Foote R L. External-beam radiation therapy in the treatment of diffuse tracheobronchial amyloidosis.  Mayo Clin Proc. 2001;  76 853-856
    PubMedGoogle Scholar
  • 139 Kurrus J A, Hayes J K, Hoidal J R, Menendez M M, Elstad M R. Radiation therapy for tracheobronchial amyloidosis.  Chest. 1998;  114 1489-1492
    PubMedGoogle Scholar
  • 140 Nugent A M, Elliott H, McGuigan J A, Varghese G. Pulmonary amyloidosis: treatment with laser therapy and systemic steroids.  Respir Med. 1996;  90 433-435
    PubMedGoogle Scholar
  • 141 Skinner M, Anderson J, Simms R et al.. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only.  Am J Med. 1996;  100 290-298
    CrossrefPubMedGoogle Scholar
  • 142 Kyle R A, Gertz M A, Greipp P R et al.. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine.  N Engl J Med. 1997;  336 1202-1207
    CrossrefPubMedGoogle Scholar
  • 143 Skinner M, Sanchorawala V, Seldin D C et al.. High-dose Melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study.  Ann Intern Med. 2004;  140 85-93
    PubMedGoogle Scholar
  • 144 Ware L B, Keith F M, Gordon R L et al.. Lung transplantation for pulmonary amyloidosis: a case report.  J Heart Lung Transplant. 1998;  17 1129-1132
    PubMedGoogle Scholar

Jean-François CordierM.D. 

Claude Bernard University, Department of Respiratory Medicine-Reference Center for Orphan Pulmonary Diseases

Louis Pradel University Hospital, 28 avenue du Doyen Lépine

69677 Lyon (Bron), France

Email: jean-francois.cordier@chu-lyon.fr

      >